Novartis Wins Bone Drug Injury Suit On Timeliness

Law360, New York (August 31, 2012, 4:07 PM EDT) -- A Rhode Island magistrate judge has held that the court should rule in favor of Novartis Pharmaceuticals Corp. in a suit claiming a now-deceased woman allegedly developed a jaw condition from taking the bone drug Aredia, saying the claims are time-barred.

U.S. Magistrate Judge Lincoln Almond recommended on Aug. 28 that Novartis be granted summary judgment in a suit concerning Massachusetts resident Margaret Patterson, who took Aredia from 2000 to 2006 to treat her osteoporosis and developed osteonecrosis of the jaw as a result, according to...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Patterson et al v. Novartis Pharmaceuticals Corporation


Case Number

1:11-cv-00402

Court

Rhode Island

Nature of Suit

P.I.: Other

Judge

Mary M. Lisi

Date Filed

September 8, 2011

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.